BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 430357)

  • 1. Pharmacokinetics and cardiopulmonary effects in dogs of sublingual pirbuterol, a new bronchodilator.
    Constantine JW; McIlhenny HM; Moore PF
    J Pharmacol Exp Ther; 1979 Mar; 208(3):371-6. PubMed ID: 430357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bronchodilating and cardiovascular effects of intraduodenally and orally administered clenbuterol in dogs.
    Kato H; Nakayama K; Takata Y; Kurihara J; Sakai T; Iwata K; Yamamoto I
    Arzneimittelforschung; 1985; 35(7):1037-41. PubMed ID: 4052137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the haemodynamic and hypokalaemic effects of inhaled pirbuterol and salbutamol.
    Windom H; Grainger J; Burgess C; Crane J; Pearce N; Beasley R
    N Z Med J; 1990 Jun; 103(891):259-61. PubMed ID: 1972557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pirbuterol, a selecttve beta2 adrenergic bronchodilator.
    Moore PF; Constantine JW; Barth WE
    J Pharmacol Exp Ther; 1978 Nov; 207(2):410-8. PubMed ID: 712629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maximum bronchodilator effect of pirbuterol and procaterol administered as sprays with and without an aerochamber.
    Solé D; Villalba SR; Sestelo MR; Scalabrin DM; Soares FJ; Naspitz CK
    Rev Paul Med; 1993; 111(3):397-402. PubMed ID: 8108632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on bitolterol, di-p-toluate ester of N-tert.-butylarterenol: a new long-acting bronchodilator with reduced cardiovascular effects.
    Minatoya H
    J Pharmacol Exp Ther; 1978 Sep; 206(3):515-27. PubMed ID: 702319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The bronchodilator and cardiac stimulant effects of Thll65a, salbutamol and isoproterenol.
    Giles RE; Williams JC; Finkel MP
    J Pharmacol Exp Ther; 1973 Sep; 186(3):472-81. PubMed ID: 4147005
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effects of theophylline and doxofylline on airway responsiveness in beagles].
    Sugeta A; Imai T; Idaira K; Horikoshi S; Okamoto M; Adachi M
    Arerugi; 1997 Jan; 46(1):7-15. PubMed ID: 9078607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on carbuterol (SK & F 40383-A), a new selective bronchodilator agent.
    Wardell JR; Colella DF; Shetzline A; Fowler PJ
    J Pharmacol Exp Ther; 1974 Apr; 189(1):167-84. PubMed ID: 4823290
    [No Abstract]   [Full Text] [Related]  

  • 10. [Studies on nifedipine, a coronary vasodilator agent with rapid sublingual effects].
    Raff WK; Kosche F; Lochner W
    Arzneimittelforschung; 1972 Jan; 22(1):33-9. PubMed ID: 5066995
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of six months of daily treatment with the beta-2 agonist oral pirbuterol on pulmonary hemodynamics in patients with chronic hypoxic cor pulmonale receiving long-term oxygen therapy.
    Biernacki W; Prince K; Whyte K; MacNee W; Flenley DC
    Am Rev Respir Dis; 1989 Feb; 139(2):492-7. PubMed ID: 2563321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological studies with the alpha 2-adrenoceptor antagonist midaglizole. Part I: Respiratory and cardiovascular systems.
    Hirohashi M; Takasuna K; Yamashita N; Tamura K
    Arzneimittelforschung; 1991 Jan; 41(1):9-18. PubMed ID: 1675573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of increasing dosage of an inhaled beta-2 specific agonist on pulmonary function, tremor, and cardiovascular indices.
    Tinkelman DG; Lutz C
    Ann Allergy; 1992 Jan; 68(1):23-6. PubMed ID: 1346562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term oral bronchodilator therapy of asthma with pirbuterol.
    Burki NK; Diamond L
    Clin Pharmacol Ther; 1978 Jul; 24(1):84-9. PubMed ID: 657723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aerosol pirbuterol: bronchodilator activity and side effects in ponies with recurrent airway obstruction (heaves).
    Derksen FJ; Robinson NE; Berney CE
    Equine Vet J; 1992 Mar; 24(2):107-12. PubMed ID: 1582387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyrbuterol: a new bronchodilator. Phase I-single dose study.
    Steen SN; Ziment I; Thomas JS
    Curr Ther Res Clin Exp; 1974 Oct; 16(10):1077-81. PubMed ID: 4215618
    [No Abstract]   [Full Text] [Related]  

  • 17. Dose-related cardiovascular effects of amrinone during enflurane anesthesia in the dog.
    Makela VH; Kapur PA
    Anesth Analg; 1986 Aug; 65(8):849-52. PubMed ID: 3729021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Respiratory and cardiovascular effects of prostaglandins in the conscious guinea pig.
    Weissberg RM; Marian J; Bradshaw J
    J Pharmacol Exp Ther; 1976 Jul; 198(1):197-208. PubMed ID: 933007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. General pharmacology of the new antimuscarinic compound vamicamide.
    Yamamoto T; Honbo T; Tokoro K; Kojimoto Y; Kodama R; Ohtsuka M; Shimomura K
    Arzneimittelforschung; 1995 Dec; 45(12):1274-84. PubMed ID: 8595084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute bronchial and cardiovascular effects of oral pirbuterol and metaproterenol.
    Ence TJ; Tashkin DP; Ho D; Child JS
    Ann Allergy; 1979 Oct; 43(4):229-36. PubMed ID: 555600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.